India's Cipla cuts prices of three cancer drugs The Pharma Letter Lung cancer drug Erlocip would cost Rs 9,900 rupees for 30 tablets down from 27,000 rupees and 3,700 rupees for 10 tablets, down from 10,000 rupees. Erlotinib is the drug for which Cipla recently won a patent litigation battle with the Swiss drug major ... |
